Peptides and building blocks

Bioconjugation building blocks and proprietary peptides.

C0101

C0101

Specifications:

  • Sequence: c[YRGDLAYp(NMe)K]
  • Synonyms: "Tyr2"
  • Composition: TFA salt
  • Appearance: microcrystalline, colourless powder
  • MW: 1078
  • Purity: > 95 % (UPLC, 210-220 nm)
  • Filling size: 1, 10, 100, 500, 1000 mg (net peptide)
  • Purpose: Not for human use
C0201

C0201

Specifications:

  • Sequence: c[YRGDLAYp(NMe)K(4-pentynoic amide)]
  • Synonyms: "Tyr2-alkyne"
  • Composition: TFA salt
  • Appearance: microcrystalline, colourless powder
  • MW: 1157
  • Purity: > 95 % (UPLC, 210-220 nm)
  • Filling size: 1, 10, 100, 500, 1000 mg (net peptide)
  • Purpose: Not for human use
C0301

C0301

Specifications:

  • Sequence: c[Y(tBu)R(Pbf)GD(tBu)LAY(tBu)p(NMe)K]
  • Synonyms: "protected Tyr2"
  • Composition: TFA salt
  • Appearance: microcrystalline, colourless powder
  • MW: 1499
  • Purity: > 95 % (UPLC, 210-220 nm)
  • Filling size: 1, 10, 100, 500, 1000 mg (net peptide)
  • Purpose: Not for human use
Trivehexin

Trivehexin

Specifications:

  • Compound: TRAP-(N3-c[YRGDLAYp(NMe)K])3
  • Composition: TFA salt/Hydrate
  • Appearance: microcrystalline, colourless powder
  • MW: 4296
  • Purity: > 97 % (HPLC, 210-220 nm)
  • Filling size: Various
  • Purpose: Not for human use
  • Availability notice: No shipping to USA, Australia, Japan, China and Hongkong
Ga-Trivehexin

Ga-Trivehexin

Specifications:

  • Compound: natGa-TRAP-(N3-c[YRGDLAYp(NMe)K])3
  • Composition: Salt (HCl, AcOH)/Hydrate
  • Appearance: microcrystalline, colourless powder
  • MW: 4363
  • Purity: > 95 % (HPLC, 210-220 nm)
  • Filling size: 500 µg
  • Purpose: Standard for identity analysis
  • Availability notice: No shipping to USA, Australia, Japan, China and Hongkong
Triveoctin

Triveoctin

Specifications:

  • Compound: TRAP-(N3-c[GVRGDVp(NMe)K])3
  • Composition: TFA salt/Hydrate
  • Appearance: microcrystalline, colourless powder
  • MW: 3615
  • Purity: > 95 % (HPLC, 210-220 nm)
  • Filling size: Various
  • Purpose: Not for human use
TRAP

TRAP

Specifications:

  • Compound: 1,4,7-triazacyclononane-1,4,7-tris[(2-carboxyethylmethyl)pentynoic acid]
  • Composition: hydrate (1-2 H2O)
  • Appearance: microcrystalline, colourless powder
  • MW: 579
  • Purity: > 98 % (NMR)
  • Filling size: 1 g
  • Purpose: Chelating agent, conjugation, multimerisation
TRAP Triazide

TRAP Triazide

Specifications:

  • Compound: TRAP-(HN-CH2CH2CH2-N3)3
  • Composition: TFA salt/hydrate
  • Appearance: Colourless viscous liquid
  • MW: 825
  • Purity: > 97 % (HPLC, 210-220 nm)
  • Filling size: 100 mg
  • Purpose: Chelating agent, conjugation, multimerisation
DOTPI

DOTPI

Specifications:

  • Compound: 1,4,7,10-tetraazacyclododecane-1,4,7-10-tetrakis[(2-carboxyethylmethyl)pentynoic acid]
  • Composition: hydrate (1-3 H2O)
  • Appearance: microcrystalline, colourless powder
  • MW: 772
  • Purity: > 98 % (NMR)
  • Filling size: 1 g
  • Purpose: Chelating agent, conjugation, multimerisation
DOTPI Tetraazide

DOTPI Tetraazide

Specifications:

  • Compound: DOTPI-(HN-CH2CH2CH2-N3)4
  • Composition: TFA salt/hydrate
  • Appearance: Colourless viscous liquid
  • MW: 1100
  • Purity: > 97 % (HPLC, 210-220 nm)
  • Filling size: 100 mg
  • Purpose: Chelating agent, conjugation, multimerisation
DOTPI Triazide

DOTPI Triazide

Specifications:

  • Compound: DOTPI-(HN-CH2CH2CH2-N3)3
  • Composition: TFA salt/hydrate
  • Appearance: Colourless viscous liquid
  • MW: 1018
  • Purity: > 97 % (HPLC, 210-220 nm)
  • Filling size: 100 mg
  • Purpose: Chelating agent, conjugation, multimerization, heteromultimerisation
3-Azidopropyl amine

3-Azidopropyl amine

Specifications:

  • Compound: H2N-(CH2)3-N3
  • Composition: Free amine
  • Appearance: Colourless to yellowish viscous liquid
  • MW: 100
  • Purity: > 95 % (NMR)
  • Filling size: 1 g
  • Purpose: Linker
ask for quote link

IMPORTANT NOTICE:
The offered peptides are for non-commercial and/or research purposes only (chemistry, biological evaluation and preclinical use). The buyer has no rights to use the peptides for any commercial manufacturing and/or reselling the peptides in any form (crude, modified, conjugated, radiolabelled). None of the offered compounds is meant/available for human use.